Pathkey.ai Limited has released a press release.
Appendix 4C - monthly
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Pathkey.AI
- Cancer Trials Australia becomes MediaConsent collaborator
- Capital Raise and Strategic Acquisition of Ludomade
- Collaboration announced with Neuroscience Trials Australia
- SRO partners with Secure One Button Login experts SAAVHA
- Quarterly Report & Appendix 4C
Later from Pathkey.AI
- Pause in Trade
- Changes to Board of Directors
- Reinstatement to Trading on the ASX
- Half Year Financial Report & Appendix 4D
- Michelle Gallaher appointed SRO CEO
Follow Pathkey.AI into a list and get an email when it puts out news.
Follow Pathkey.AI